Mohammad Hassan Bastanhagh

Publications (4)6.8 Total impact

• Source

  Available from: indexcopernicus.com

  Article: Evaluation of the efficacy of blood glucose home monitoring devices.

  Mohammad Hassan Bastanhagh, Adeleh Rezagholizadeh Shirvan, Ramin Heshmat, Alireza Khalilifard, Abbasali Keshtkar, Bagher Larijani
  [show abstract] [hide abstract]
  ABSTRACT: An important component of diabetes care is self-monitoring blood glucose (BG). Up to now, no standard quality control procedure has verified the readings of various blood glucose meters in Iran. The purpose of this study was to compare the efficacy of three glucose meters and Betachek (a visual BG measurement test) with the measurement of a reference laboratory. The Betachek test strip and three other common glucometer devices in Iran (Glucotrend 2, GlucoMen, and GlucoCare) were used to determine BG levels in 110 patients suffering from diabetes. The results were then compared with a standard laboratory method. The mean measurement of blood glucose by GlucoCare showed the least deviation from the standard laboratory method (6.80% less than the standard method). Glucotrend 2 had the best correlation with the standard method. The mean deviations in BG level as read by GlucoMen, Glucotrend 2, and Betachek were 9.53%, 11.95%, and 10.26% higher than the standard method, respectively. Betachek showed the lowest correlation with the standard method. GlucoCare and Glucotrend 2 had the most advantageous results; however, no glucometer met the ADA criteria of reading within 5% of the laboratory reference results. Betachek had the least reliable readings.
  Medical science monitor: international medical journal of experimental and clinical research 04/2007; 13(3):PI1-6. · 1.70 Impact Factor
• Article: Dermopathy and retinopathy in diabetes: is there an association?

  Ali Abdollahi, Maryam Daneshpazhooh, Elham Amirchaghmaghi, Samira Sheikhi, Babak Eshrati, Mohammad-Hassan Bastanhagh
  [show abstract] [hide abstract]
  ABSTRACT: Diabetic dermopathy is the most common cutaneous marker of diabetes mellitus presenting as single or multiple well-demarcated brown atrophic macules, predominantly on the shins. Although diabetic dermopathy and diabetic retinopathy are both considered by some authors as manifestations of diabetic microangiopathy, only a few studies are published about their possible association. Our purpose was to investigate the association of diabetic dermopathy and diabetic retinopathy. We conducted a cross-sectional study in an outpatient diabetes clinic during a 6-month period. One-hundred and eighty-one consecutive patients (8 cases of insulin-dependent diabetes mellitus and 173 cases of non-insulin-dependent diabetes mellitus) were examined for the presence of diabetic dermopathy and diabetic retinopathy. Forty-seven (26%) showed diabetic dermopathy and 68 patients (37.6%) suffered from diabetic retinopathy. The frequency of retinopathy in patients with diabetic dermopathy (44%; 30 cases) was significantly greater than in patients without dermopathy (15%; 17 cases; p < 0.0001). Retinopathy showed a statistically significant association with dermopathy [odds ratio (OR): 3.60; 95% confidence interval (CI): 1.53-8.44; p = 0.003] and diabetes duration (OR: 3.36; 95% CI: 1.67-6.77; p = 0.001). Our study further supports that diabetic dermopathy might be used as a telltale sign of diabetic retinopathy, necessitating more intensive ophthalmologic care, especially in long-lasting diabetes.
  Dermatology 01/2007; 214(2):133-6. · 2.05 Impact Factor
• Source

  Available from: PubMed Central

  Article: Treatment of hyperfunctioning thyroid nodules by percutaneous ethanol injection.

  Bagher Larijani, Mohammad Pajouhi, Hossein Ghanaati, Mohammad-Hassan Bastanhagh, Fereshteh Abbasvandi, Kazem Firooznia, Mahmood Shirzad, Mohammad-Reza Amini, Maryam Sarai, Nasreen Abbasvandi, Reza Baradar-Jalili
  [show abstract] [hide abstract]
  ABSTRACT: BACKGROUND: Autonomous thyroid nodules can be treated by a variety of methods. We assessed the efficacy of percutaneous ethanol injection in treating autonomous thyroid nodules. METHODS: 35 patients diagnosed by technetium-99 scanning with hyperfunctioning nodules and suppressed sensitive TSH (sTSH) were given sterile ethanol injections under ultrasound guidance. 29 patients had clinical and biochemical hyperthyroidism. The other 6 had sub-clinical hyperthyroidism with suppressed sTSH levels (<0.24 &mgr;IU/ml) and normal thyroid hormone levels. Ethanol injections were performed once every 1-4 weeks. Ethanol injections were stopped when serum T3, T4 and sTSH levels had returned to normal, or else injections could no longer be performed because significant side effects. Patients were followed up at 3, 6 and, in 15 patients, 24 months after the last injection. RESULTS: Average pre-treatment nodule volume [18.2 PlusMinus; 12.7 ml] decreased to 5.7 PlusMinus; 4.6 ml at 6 months follow-up [P < 0.001]. All patients had normal thyroid hormone levels at 3 and 6 months follow-up [P < 0.001 relative to baseline]. sTSH levels increased from 0.09 PlusMinus; 0.02 &mgr;IU/ml to 0.65 PlusMinus; 0.8 &mgr;IU/ml at the end of therapy [P < 0.05]. Only 3 patients had persistent sTSH suppression at 6 months post-therapy. T4 and sTSH did not change significantly between 6 months and 2 years [P > 0.05]. Ethanol injections were well tolerated by the patients, with only 2 cases of transient dysphonia. CONCLUSION: Our findings indicate that ethanol injection is an alternative to surgery or radioactive iodine in the treatment of autonomous thyroid nodules.
  BMC Endocrine Disorders 12/2002; 2(1):3. · 2.16 Impact Factor
• Article: Primary thyroid malignancies in Tehran, Iran.

  Bagher Larijani, Mohammad Ali Mohagheghi, Mohammad Hassan Bastanhagh, Ali Reza Mosavi-Jarrahi, Vahid Haghpanah, Seyed Mohammad Tavangar, Fatemeh Bandarian, Nasim Khaleghian
  [show abstract] [hide abstract]
  ABSTRACT: The aim of this study was to present a descriptive epidemiology of primary thyroid cancer in Tehran, Iran, using cancer registry data. All cases of thyroid cancer registered from 1998 to 2001 in Tehran Metropolitan Area Population-Based Cancer Registry were used for this study. The incidence of thyroid cancer was estimated for the area covered by the cancer registry. Survival of patients was ascertained by telephone call to the patients or the patient's family and/or linkage of registry data to mortality data from the Bureau of Vital Statistics. Patient's survival was based on sex, age and morphological type of tumour. Four hundred and twenty-nine cases of primary thyroid cancer were registered in the Tehran Metropolitan Area Cancer Registry. The incidence of thyroid cancer was 3.5 and 1.0 per 100,000 population per year for females and males, respectively. Seventy percent of tumours were papillary, 11% follicular, 6.2% medullary, and the rest were other subtypes. The papillary and follicular variants occurred in younger age: 43 +/- 16 and 46 +/- 13 years, respectively; the medullary and anaplastic variants occurred in older age: over 50 years. A 5-year survival rate was 82.2%, with median survival of 66 months and 95% confidence interval of 63 and 69 months. Men and women had a similar survival experience. While the incidence of thyroid cancer was slightly high, the descriptive epidemiology of thyroid cancer in Tehran did not manifest a unique feature. Tehran patients experienced a high rate of survival, and the survival time for males and females was similar.
  Medical Principles and Practice 14(6):396-400. · 0.89 Impact Factor